DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit After Tax | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
Year | Profit After Tax |
---|---|
Mar2025 | ₹2,191 Cr |
Mar2024 | ₹1,600 Cr |
Mar2023 | ₹1,824 Cr |
Mar2022 | ₹2,960 Cr |
Mar2021 | ₹1,984 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹2,191 Cr | 36.94 | |
Mar2024 | ₹1,600 Cr | -12.28 | |
Mar2023 | ₹1,824 Cr | -38.39 | |
Mar2022 | ₹2,960 Cr | 49.19 | |
Mar2021 | ₹1,984 Cr | - |
Compare Profit After Tax of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹175,726.5 Cr | 1% | 9.4% | 8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,872.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
CIPLA | ₹127,449.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,125.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,827.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics | |
MANKIND PHARMA | ₹102,292.0 Cr | 1.5% | -3.5% | -10.6% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1% |
9.4% |
8% |
SENSEX | 1.8% |
1.9% |
2.4% |
You may also like the below Video Courses